Annual EBIT
-$21.80 M
+$9.00 M+29.22%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual earnings before interest & taxes is -$21.80 million, with the most recent change of +$9.00 million (+29.22%) on December 31, 2022.
- During the last 3 years, LMNL annual EBIT has risen by +$86.72 million (+79.91%).
Performance
LMNL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$6.69 M
-$1.08 M-19.28%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly earnings before interest & taxes is -$6.69 million, with the most recent change of -$1.08 million (-19.28%) on June 30, 2023.
- Over the past year, LMNL quarterly EBIT has dropped by -$2.29 million (-52.10%).
Performance
LMNL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$23.70 M
-$2.29 M-10.71%
June 30, 2023
Summary
- As of February 10, 2025, LMNL TTM earnings before interest & taxes is -$23.70 million, with the most recent change of -$2.29 million (-10.71%) on June 30, 2023.
- Over the past year, LMNL TTM EBIT has increased by +$237.80 thousand (+0.99%).
Performance
LMNL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LMNL EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +29.2% | -52.1% | +1.0% |
3 y3 years | +79.9% | +28.7% | -10.2% |
5 y5 years | +78.0% | +69.3% | +78.0% |
LMNL EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +41.3% | +52.1% | +15.9% | +10.7% | +30.0% |
5 y | 5-year | at high | +397.8% | -123.7% | +186.4% | +186.6% | +365.2% |
alltime | all time | -1029.3% | +748.5% | -123.7% | +1624.5% | -695.0% | +959.8% |
Liminal BioSciences EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | -$6.69 M(+19.3%) | -$23.70 M(+10.7%) |
Mar 2023 | - | -$5.61 M(+4.9%) | -$21.41 M(-9.1%) |
Dec 2022 | -$21.80 M(-29.2%) | -$5.35 M(-11.6%) | -$23.56 M(-0.9%) |
Sep 2022 | - | -$6.05 M(+37.5%) | -$23.77 M(-0.7%) |
Jun 2022 | - | -$4.40 M(-43.3%) | -$23.94 M(-15.8%) |
Mar 2022 | - | -$7.76 M(+39.4%) | -$28.45 M(-7.7%) |
Dec 2021 | -$30.80 M(-10.9%) | -$5.56 M(-10.6%) | -$30.81 M(-8.7%) |
Sep 2021 | - | -$6.22 M(-30.1%) | -$33.74 M(-4.7%) |
Jun 2021 | - | -$8.90 M(-12.0%) | -$35.41 M(-1.3%) |
Mar 2021 | - | -$10.12 M(+19.2%) | -$35.89 M(-20.1%) |
Dec 2020 | -$34.58 M(-68.1%) | -$8.49 M(+7.6%) | -$44.94 M(+443.5%) |
Sep 2020 | - | -$7.89 M(-15.9%) | -$8.27 M(-61.6%) |
Jun 2020 | - | -$9.39 M(-51.0%) | -$21.51 M(-80.5%) |
Mar 2020 | - | -$19.17 M(-168.0%) | -$110.27 M(+2.5%) |
Dec 2019 | -$108.52 M(-41.3%) | $28.18 M(-233.3%) | -$107.61 M(-57.2%) |
Sep 2019 | - | -$21.14 M(-78.5%) | -$251.21 M(+0.1%) |
Jun 2019 | - | -$98.14 M(+494.3%) | -$250.91 M(+43.7%) |
Mar 2019 | - | -$16.51 M(-85.7%) | -$174.59 M(-4.7%) |
Dec 2018 | -$184.98 M(+86.8%) | -$115.42 M(+453.8%) | -$183.18 M(+66.9%) |
Sep 2018 | - | -$20.84 M(-4.5%) | -$109.76 M(+8.8%) |
Jun 2018 | - | -$21.82 M(-13.1%) | -$100.92 M(-1.1%) |
Mar 2018 | - | -$25.10 M(-40.2%) | -$102.02 M(+3.2%) |
Dec 2017 | -$99.05 M(+16.7%) | -$42.00 M(+249.9%) | -$98.87 M(+13.5%) |
Sep 2017 | - | -$12.00 M(-47.6%) | -$87.11 M(-9.9%) |
Jun 2017 | - | -$22.91 M(+4.4%) | -$96.66 M(+3.5%) |
Mar 2017 | - | -$21.95 M(-27.4%) | -$93.37 M(+9.8%) |
Dec 2016 | -$84.89 M(+84.6%) | -$30.24 M(+40.3%) | -$85.01 M(+31.9%) |
Sep 2016 | - | -$21.55 M(+9.9%) | -$64.45 M(+25.6%) |
Jun 2016 | - | -$19.62 M(+44.3%) | -$51.31 M(+18.4%) |
Mar 2016 | - | -$13.60 M(+40.6%) | -$43.31 M(-6.3%) |
Dec 2015 | -$45.99 M(-2060.3%) | -$9.67 M(+15.0%) | -$46.25 M(+48.5%) |
Sep 2015 | - | -$8.41 M(-27.7%) | -$31.13 M(-24.0%) |
Jun 2015 | - | -$11.63 M(-29.7%) | -$40.95 M(+461.6%) |
Mar 2015 | - | -$16.53 M(-404.0%) | -$7.29 M(-434.1%) |
Dec 2014 | $2.35 M(-115.7%) | $5.44 M(-129.8%) | $2.18 M(-122.8%) |
Sep 2014 | - | -$18.23 M(-182.7%) | -$9.59 M(-340.8%) |
Jun 2014 | - | $22.03 M(-412.1%) | $3.98 M(-119.7%) |
Mar 2014 | - | -$7.06 M(+11.4%) | -$20.19 M(+35.9%) |
Dec 2013 | -$14.97 M(-1513.6%) | -$6.34 M(+36.1%) | -$14.86 M(+108.8%) |
Sep 2013 | - | -$4.66 M(+117.3%) | -$7.12 M(-1957.9%) |
Jun 2013 | - | -$2.14 M(+24.1%) | $383.10 K(-89.5%) |
Mar 2013 | - | -$1.73 M(-222.8%) | $3.67 M(+239.5%) |
Dec 2012 | $1.06 M(-155.0%) | $1.41 M(-50.6%) | $1.08 M(-66.9%) |
Sep 2012 | - | $2.85 M(+149.7%) | $3.26 M(-338.9%) |
Jun 2012 | - | $1.14 M(-126.4%) | -$1.37 M(-66.6%) |
Mar 2012 | - | -$4.31 M(-220.2%) | -$4.09 M(+106.9%) |
Dec 2011 | -$1.93 M(-78.4%) | $3.59 M(-301.4%) | -$1.98 M(-78.5%) |
Sep 2011 | - | -$1.78 M(+12.3%) | -$9.18 M(-9.1%) |
Jun 2011 | - | -$1.59 M(-27.9%) | -$10.10 M(+12.4%) |
Mar 2011 | - | -$2.20 M(-39.2%) | -$8.98 M(-4.5%) |
Dec 2010 | -$8.90 M | -$3.62 M(+34.1%) | -$9.41 M(+25.0%) |
Sep 2010 | - | -$2.70 M(+474.8%) | -$7.53 M(+45.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2010 | - | -$469.40 K(-82.1%) | -$5.18 M(-38.8%) |
Mar 2010 | - | -$2.63 M(+51.3%) | -$8.48 M(+18.6%) |
Dec 2009 | -$7.23 M(-53.4%) | -$1.74 M(+389.4%) | -$7.15 M(-18.1%) |
Sep 2009 | - | -$354.60 K(-90.6%) | -$8.72 M(-22.4%) |
Jun 2009 | - | -$3.76 M(+190.3%) | -$11.24 M(-8.3%) |
Mar 2009 | - | -$1.30 M(-60.9%) | -$12.25 M(-22.3%) |
Dec 2008 | -$15.51 M(-18.1%) | -$3.31 M(+15.2%) | -$15.77 M(-15.1%) |
Sep 2008 | - | -$2.87 M(-39.9%) | -$18.57 M(-14.2%) |
Jun 2008 | - | -$4.78 M(-0.7%) | -$21.65 M(+5.1%) |
Mar 2008 | - | -$4.81 M(-21.3%) | -$20.59 M(+7.4%) |
Dec 2007 | -$18.94 M(-6.1%) | -$6.11 M(+2.7%) | -$19.17 M(+2.0%) |
Sep 2007 | - | -$5.95 M(+60.1%) | -$18.80 M(-1.4%) |
Jun 2007 | - | -$3.72 M(+9.8%) | -$19.06 M(-0.6%) |
Mar 2007 | - | -$3.39 M(-41.0%) | -$19.18 M(-6.9%) |
Dec 2006 | -$20.18 M(+63.8%) | -$5.74 M(-7.7%) | -$20.59 M(+13.0%) |
Sep 2006 | - | -$6.22 M(+62.0%) | -$18.22 M(+13.9%) |
Jun 2006 | - | -$3.84 M(-20.0%) | -$16.00 M(-1.9%) |
Mar 2006 | - | -$4.80 M(+42.6%) | -$16.31 M(+32.3%) |
Dec 2005 | -$12.32 M(+13.5%) | -$3.36 M(-15.8%) | -$12.33 M(+5.0%) |
Sep 2005 | - | -$4.00 M(-3.7%) | -$11.74 M(+7.5%) |
Jun 2005 | - | -$4.15 M(+411.6%) | -$10.92 M(+39.5%) |
Mar 2005 | - | -$811.70 K(-70.8%) | -$7.83 M(-28.6%) |
Dec 2004 | -$10.86 M(-26.3%) | -$2.78 M(-12.7%) | -$10.97 M(-13.8%) |
Sep 2004 | - | -$3.18 M(+200.4%) | -$12.73 M(-2.5%) |
Jun 2004 | - | -$1.06 M(-73.2%) | -$13.06 M(-17.8%) |
Mar 2004 | - | -$3.95 M(-12.9%) | -$15.90 M(+7.4%) |
Dec 2003 | -$14.73 M(+60.5%) | -$4.54 M(+29.5%) | -$14.81 M(+13.8%) |
Sep 2003 | - | -$3.51 M(-9.9%) | -$13.01 M(+12.0%) |
Jun 2003 | - | -$3.89 M(+36.0%) | -$11.62 M(+14.9%) |
Mar 2003 | - | -$2.86 M(+4.1%) | -$10.11 M(+10.2%) |
Dec 2002 | -$9.18 M(+67.6%) | -$2.75 M(+30.4%) | -$9.18 M(+12.5%) |
Sep 2002 | - | -$2.11 M(-11.7%) | -$8.16 M(+12.5%) |
Jun 2002 | - | -$2.39 M(+23.8%) | -$7.26 M(+15.9%) |
Mar 2002 | - | -$1.93 M(+11.5%) | -$6.26 M(+14.6%) |
Dec 2001 | -$5.48 M(+60.5%) | -$1.73 M(+43.7%) | -$5.46 M(+20.7%) |
Sep 2001 | - | -$1.20 M(-13.7%) | -$4.53 M(+4.7%) |
Jun 2001 | - | -$1.40 M(+23.3%) | -$4.32 M(+15.7%) |
Mar 2001 | - | -$1.13 M(+42.8%) | -$3.74 M(+13.5%) |
Dec 2000 | -$3.41 M(+12.7%) | -$792.70 K(-20.8%) | -$3.29 M(+87.9%) |
Sep 2000 | - | -$1.00 M(+23.5%) | -$1.75 M(-16.4%) |
Jun 2000 | - | -$810.60 K(+17.8%) | -$2.10 M(-18.6%) |
Mar 2000 | - | -$688.00 K(-192.1%) | -$2.58 M(-14.5%) |
Dec 1999 | -$3.03 M(+66.2%) | $747.30 K(-155.6%) | -$3.01 M(-28.5%) |
Sep 1999 | - | -$1.35 M(+4.3%) | -$4.21 M(+24.0%) |
Jun 1999 | - | -$1.29 M(+14.8%) | -$3.40 M(-0.7%) |
Mar 1999 | - | -$1.12 M(+147.6%) | -$3.42 M(-1.9%) |
Dec 1998 | -$1.82 M(-49.0%) | -$454.00 K(-14.1%) | -$3.49 M(-19.1%) |
Sep 1998 | - | -$528.60 K(-59.8%) | -$4.31 M(+14.0%) |
Jun 1998 | - | -$1.31 M(+10.4%) | -$3.78 M(+53.2%) |
Mar 1998 | - | -$1.19 M(-6.9%) | -$2.47 M(+93.1%) |
Dec 1997 | - | -$1.28 M | -$1.28 M |
Sep 1997 | -$3.58 M | - | - |
FAQ
- What is Liminal BioSciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Liminal BioSciences?
- What is Liminal BioSciences annual EBIT year-on-year change?
- What is Liminal BioSciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Liminal BioSciences?
- What is Liminal BioSciences quarterly EBIT year-on-year change?
- What is Liminal BioSciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Liminal BioSciences?
- What is Liminal BioSciences TTM EBIT year-on-year change?
What is Liminal BioSciences annual earnings before interest & taxes?
The current annual EBIT of LMNL is -$21.80 M
What is the all time high annual EBIT for Liminal BioSciences?
Liminal BioSciences all-time high annual earnings before interest & taxes is $2.35 M
What is Liminal BioSciences annual EBIT year-on-year change?
Over the past year, LMNL annual earnings before interest & taxes has changed by +$9.00 M (+29.22%)
What is Liminal BioSciences quarterly earnings before interest & taxes?
The current quarterly EBIT of LMNL is -$6.69 M
What is the all time high quarterly EBIT for Liminal BioSciences?
Liminal BioSciences all-time high quarterly earnings before interest & taxes is $28.18 M
What is Liminal BioSciences quarterly EBIT year-on-year change?
Over the past year, LMNL quarterly earnings before interest & taxes has changed by -$2.29 M (-52.10%)
What is Liminal BioSciences TTM earnings before interest & taxes?
The current TTM EBIT of LMNL is -$23.70 M
What is the all time high TTM EBIT for Liminal BioSciences?
Liminal BioSciences all-time high TTM earnings before interest & taxes is $3.98 M
What is Liminal BioSciences TTM EBIT year-on-year change?
Over the past year, LMNL TTM earnings before interest & taxes has changed by +$237.80 K (+0.99%)